Answers are grounded in this paper and cite their sources.
The study protocol has been approved by the Clinical Trials Information System (CTIS) of the European Medicines Agency (EMA), study number: 2023-506213-21-00 and the trial has been registered in ClinicalTrials.gov, NCT06210269.
No takes yet. Share an insight, caveat, or question.
LUND et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: